Clinical Trials in Nashville

Showing 2221-2240 of 17,403 trials

A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures

NCT07219407

This is a clinical research study for an investigational drug called RAP-219 in patients with Refractory Focal Epilepsy. This study is being conducted to determine RAP-219 Long- term safety and open-label antiseizure activity in patients with Refractory Focal Epilepsy.

Focal EpilepsyEpilepsyRefractory Focal Epilepsy+3 more

Rapport Therapeutics Inc.30 participantsStarted Dec 2025

Boise, Idaho, United States • Rochester, Minnesota, United States • New York, New York, United States +4 more locations

RECRUITINGPhase 3< 1 mile

Abatacept for the Treatment of Giant Cell Arteritis

NCT04474847

This randomized, double-blind, placebo-controlled trial will seek to determine the efficacy of abatacept in GCA. To examine this objective, 62 eligible patients who have newly diagnosed or relapsing GCA within 8 weeks prior to screening will be randomized at a 1:1 ratio to receive subcutaneous abatacept 125mg/week or placebo. Patients who achieve remission will remain on their blinded assignment for 12 months at which time abatacept/placebo will be stopped. Patients who do not achieve remission by Month 3, who experience a relapse within the first 12 months will have the option of receiving open-label abatacept for a maximum of 12 months.

Giant Cell Arteritis

University of Pennsylvania78 participantsStarted Mar 2021

Rochester, Minnesota, United States • New York, New York, United States • Cleveland, Ohio, United States +6 more locations

A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures

Abatacept for the Treatment of Giant Cell Arteritis

Find Trials by Condition in Nashville

A Randomized Multicenter Study for Isolated Skin Vasculitis

A Phase 1 Study in Patients With HPV16+ Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma

A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)

Assessment of the Ocular Microbiome in Health and Disease

Feasibility and Safety of Single-Port Robotic-Assisted Deep Inferior Epigastric Pedicle Flap Harvest

Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC

Non-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-AM

Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

ReActiv8 Stimulation Therapy vs Optimal Medical Management: A Randomized Evaluation

A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer

Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma

Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients

Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

DBT Skills Groups for Veterans at High Risk for Suicide Attempt

Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma

Robotic Minimally Invasive Inguinal Hernia Repair Post-Market Clinical Study With the DEXTER Robotic System